Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04372888 · ClinicalTrials.gov registry record · NA
Examining Choice Architecture for Genetic Testing Decisions
A NA study, sponsored by Boston College.
- Completed
- Registry status
- NA
- Development phase
- 1,012
- Enrollment target
NCT04372888: Completed NA study, sponsored by Boston College.
NCT04372888 is a NA study that has completed, run by Boston College. The registered enrollment target is 1,012 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04372888, a NA study, has completed, sponsored by Boston College.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,012 participants
- Enrollment target
Study Summary
The goal of this application is to gain a deeper understanding of decision-making for genetic testing and identify effective choice-architecture-based strategies to improve decisions in genetic testing. The investigators hypothesize that choice architecture (i.e. framing) affects decision-making for hypothetical genetic testing scenarios.
Primary Outcome
Opting "yes" for genetic testing or "no" refusing genetic testing
Interventions
- BEHAVIORAL choice decision frame
- BEHAVIORAL opt-in decision frame
- BEHAVIORAL opt-out decision frame
- BEHAVIORAL enhanced choice (context) decision frame
- BEHAVIORAL enhanced choice (norms) decision frame
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,012 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
What the finished NCT04372888 record still lists
NCT04372888 is an interventional study that assigns participants to a tested intervention. Its 1,012 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 5 interventions - of which choice decision frame is the first listed.
NCT04372888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04372888 about?
NCT04372888 is a clinical study titled "Examining Choice Architecture for Genetic Testing Decisions". The goal of this application is to gain a deeper understanding of decision-making for genetic testing and identify effective choice-architecture-based strategies to improve decisions in genetic testing. The investigators hypothesize that choice architecture (i.e. framing) affects decision-making for...
What is the current status of trial NCT04372888?
This trial is currently completed. It is a NA study. The enrollment target is 1,012 participants. The study started on 2020-03-11. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT04372888?
The interventions under investigation include: choice decision frame (BEHAVIORAL), opt-in decision frame (BEHAVIORAL), opt-out decision frame (BEHAVIORAL), enhanced choice (context) decision frame (BEHAVIORAL), enhanced choice (norms) decision frame (BEHAVIORAL).
Who is sponsoring clinical trial NCT04372888?
This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04372888's enrollment target sits among peer trials
1,012 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI